Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of insulin therapy in non-diabetic patients with acute COPD exacerbations
2007-000666-20Phase 4Terminated
- Sponsor
- Royal Bournemouth Hospital
- Start
- Apr 2007
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of insulin glulisine in chronic obstructive pulmonary disease (COPD), sponsored by Royal Bournemouth Hospital. Primary endpoint: 90-day hospital readmission rate. Started Apr 2007; status: terminated.
02
Drugs
insulin glulisine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2007-000666-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000666-20.